Search Results - "Emde-Rajaratnam M"

Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Authors: Hose D Ray S Rößler S et al.

Source: Journal of hematology & oncology [J Hematol Oncol] 2025 Jan 24; Vol. 18 (1), pp. 11. Date of Electronic Publication: 2025 Jan 24.

Publication Type: Published Erratum

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE; PubMed not MEDLINE

Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Authors: Hose D Ray S Rößler S et al.

Source: Journal of hematology & oncology [J Hematol Oncol] 2024 Dec 18; Vol. 17 (1), pp. 128. Date of Electronic Publication: 2024 Dec 18.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.

Authors: Emde-Rajaratnam M Beck S Benes V et al.

Source: Frontiers in immunology [Front Immunol] 2023 Nov 15; Vol. 14, pp. 1286700. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2023).

Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation.

Authors: Hummel M Hielscher T Emde-Rajaratnam M et al.

Source: JCO precision oncology [JCO Precis Oncol] 2024 Jul; Vol. 8, pp. e2300613.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries.

Authors: Seckinger A Salwender H Martin H et al.

Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 11; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 11.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma.

Authors: Stroh J Seckinger A Heider M et al.

Source: Blood advances [Blood Adv] 2022 Jan 25; Vol. 6 (2), pp. 515-520.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE